BioNTech SE (BNTX)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-07-23 | Phase3 Readout | — |
| 2026-07-31 | Phase3 Readout | — |
| 2026-08-01 | Phase2 Readout | — |
| 2026-10-01 | Phase1 Readout | — |
| 2026-11-01 | Phase2 Readout | — |
| 2026-11-01 | Phase1 Readout | — |
| 2026-12-01 | Phase1 Readout | — |
| 2027-06-01 | Phase1 Readout | — |
| 2027-06-01 | Phase2 Readout | — |
| 2027-06-01 | Phase2 Readout | — |
Active Clinical Trials (42)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT05543616 | A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children | PHASE3 | Active Not Recruiting | 4,292 |
| NCT04534205 | A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembroliz... | PHASE3 | Recruiting | 350 |
| NCT06712316 | Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for L... | PHASE3 | Recruiting | 1,260 |
| NCT06712355 | Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated S... | PHASE3 | Recruiting | 621 |
| NCT06018337 | A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast... | PHASE3 | Active Not Recruiting | 541 |
| NCT06265428 | A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer | PHASE3 | Active Not Recruiting | 228 |
| NCT07173751 | ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer | PHASE3 | Recruiting | 558 |
| NCT07365995 | A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer | PHASE3 | Recruiting | 736 |
| NCT07361497 | A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresec... | PHASE3 | Recruiting | 850 |
| NCT05671510 | ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors | PHASE3 | Recruiting | 630 |
| NCT07221149 | A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combinatio... | PHASE3 | Recruiting | 690 |
| NCT07300839 | A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age | PHASE3 | Active Not Recruiting | 5,240 |
| NCT07361510 | A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced No... | PHASE3 | Recruiting | 750 |
| NCT07221357 | A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combinat... | PHASE3 | Recruiting | 990 |
| NCT07291076 | A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit... | PHASE2 | Recruiting | 198 |
| NCT05150691 | A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors | PHASE2 | Recruiting | 796 |
| NCT07297212 | A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients Wit... | PHASE2 | Recruiting | 75 |
| NCT04486378 | A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, R... | PHASE2 | Active Not Recruiting | 327 |
| NCT07455734 | Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors | PHASE2 | Recruiting | 533 |
| NCT05438329 | First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors | PHASE2 | Active Not Recruiting | 1,123 |
| NCT07379580 | A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA... | PHASE2 | Recruiting | 310 |
| NCT06841055 | Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung ... | PHASE2 | Recruiting | 60 |
| NCT07079631 | A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigati... | PHASE2 | Recruiting | 482 |
| NCT06449222 | Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination ... | PHASE2 | Active Not Recruiting | 83 |
| NCT05557591 | A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in A... | PHASE2 | Active Not Recruiting | 51 |
| NCT06449209 | Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Comb... | PHASE2 | Active Not Recruiting | 110 |
| NCT06827236 | A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With An... | PHASE2 | Recruiting | 380 |
| NCT04083599 | GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors | PHASE2 | Active Not Recruiting | 350 |
| NCT05547464 | Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Va... | PHASE2 | Active Not Recruiting | 497 |
| NCT05914116 | A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors | PHASE2 | Recruiting | 862 |
| NCT07186842 | A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced ... | PHASE2 | Recruiting | 245 |
| NCT07255404 | A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works When Combined With Chemoth... | PHASE2 | Recruiting | 105 |
| NCT07293351 | A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Caboz... | PHASE2 | Recruiting | 254 |
| NCT06534983 | A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants ... | PHASE2 | Recruiting | 62 |
| NCT05968326 | A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX A... | PHASE2 | Recruiting | 260 |
| NCT07392372 | A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and Wi... | PHASE1 | Recruiting | 67 |
| NCT04503278 | A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigat... | PHASE1 | Active Not Recruiting | 214 |
| NCT06750185 | Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors | PHASE1 | Recruiting | 39 |
| NCT06150183 | Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors | PHASE1 | Active Not Recruiting | 41 |
| NCT05653752 | A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer | PHASE1 | Active Not Recruiting | 80 |
| NCT03219450 | A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL. | PHASE1 | Recruiting | 15 |
| NCT05432583 | A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, a... | PHASE1 | Active Not Recruiting | 318 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.